Nurix Therapeutics (NRIX) Q3 2025 Earnings

9JulConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.76
-0.68
-0.6
-0.52

Details

Expected EPS
-0.718688
Actual EPS
-0.52
Surprise EPS
0.2
Surprise Percent
+27.65%

Description

Nurix Therapeutics (NRIX) has reported earnings of -0.52 per share for Q3 2025.

0 Comments

Share your thoughts